Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tongji NADs Cohort: A Real-world Observation of Neurological Autoimmune Disorders

NCT07333196 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07333196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07333196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tongji NADs Cohort: A Real-world Observation of Neurological Autoimmune Disorders
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
March 1, 2037
Enrollment
1,550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute inflammatory demyelinating polyradiculoneuropathy, autoimmune encephalitis, autoimmune nodopathy, chronic inflammatory demyelinating polyradiculoneuropathy, idiopathic inflammatory myopathies, multiple sclerosis, myasthenia gravis, myelin oligodendrocyte glycoprotein antibody-associated disease, nmo spectrum disorder